Logo image of BELYS.BR

BELYSSE GROUP NV (BELYS.BR) Stock Fundamental Analysis

EBR:BELYS - Euronext Brussels - BE0974314461 - Common Stock - Currency: EUR

0.72  -0.02 (-2.7%)

Fundamental Rating

4

BELYS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 33 industry peers in the Household Durables industry. BELYS has a medium profitability rating, but doesn't score so well on its financial health evaluation. BELYS scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year BELYS was profitable.
BELYS had a positive operating cash flow in the past year.
BELYS had negative earnings in 4 of the past 5 years.
Of the past 5 years BELYS 4 years had a positive operating cash flow.
BELYS.BR Yearly Net Income VS EBIT VS OCF VS FCFBELYS.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

BELYS's Return On Assets of 3.30% is in line compared to the rest of the industry. BELYS outperforms 54.55% of its industry peers.
BELYS's Return On Equity of 11.07% is fine compared to the rest of the industry. BELYS outperforms 66.67% of its industry peers.
BELYS's Return On Invested Capital of 7.18% is in line compared to the rest of the industry. BELYS outperforms 57.58% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BELYS is significantly below the industry average of 16.96%.
The last Return On Invested Capital (7.18%) for BELYS is above the 3 year average (7.13%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.3%
ROE 11.07%
ROIC 7.18%
ROA(3y)-6.3%
ROA(5y)-7.85%
ROE(3y)-25.25%
ROE(5y)-43.19%
ROIC(3y)7.13%
ROIC(5y)5.99%
BELYS.BR Yearly ROA, ROE, ROICBELYS.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

BELYS has a Profit Margin of 3.77%. This is comparable to the rest of the industry: BELYS outperforms 54.55% of its industry peers.
With a decent Operating Margin value of 8.15%, BELYS is doing good in the industry, outperforming 72.73% of the companies in the same industry.
BELYS's Operating Margin has declined in the last couple of years.
BELYS has a better Gross Margin (60.82%) than 78.79% of its industry peers.
BELYS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.15%
PM (TTM) 3.77%
GM 60.82%
OM growth 3Y-5.23%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.7%
GM growth 5YN/A
BELYS.BR Yearly Profit, Operating, Gross MarginsBELYS.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BELYS is destroying value.
The number of shares outstanding for BELYS remains at a similar level compared to 1 year ago.
Compared to 1 year ago, BELYS has an improved debt to assets ratio.
BELYS.BR Yearly Shares OutstandingBELYS.BR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M
BELYS.BR Yearly Total Debt VS Total AssetsBELYS.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 0.34, we must say that BELYS is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.34, BELYS is doing worse than 90.91% of the companies in the same industry.
BELYS has a debt to FCF ratio of 5.56. This is a neutral value as BELYS would need 5.56 years to pay back of all of its debts.
The Debt to FCF ratio of BELYS (5.56) is better than 60.61% of its industry peers.
BELYS has a Debt/Equity ratio of 1.64. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.64, BELYS is not doing good in the industry: 87.88% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.64
Debt/FCF 5.56
Altman-Z 0.34
ROIC/WACC0.67
WACC10.8%
BELYS.BR Yearly LT Debt VS Equity VS FCFBELYS.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.78 indicates that BELYS should not have too much problems paying its short term obligations.
With a Current ratio value of 1.78, BELYS perfoms like the industry average, outperforming 57.58% of the companies in the same industry.
BELYS has a Quick Ratio of 1.78. This is a bad value and indicates that BELYS is not financially healthy enough and could expect problems in meeting its short term obligations.
BELYS has a Quick ratio of 0.95. This is in the better half of the industry: BELYS outperforms 60.61% of its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 0.95
BELYS.BR Yearly Current Assets VS Current LiabilitesBELYS.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 193.44% over the past year.
Looking at the last year, BELYS shows a decrease in Revenue. The Revenue has decreased by -6.82% in the last year.
Measured over the past years, BELYS shows a small growth in Revenue. The Revenue has been growing by 0.43% on average per year.
EPS 1Y (TTM)193.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.25%
Revenue 1Y (TTM)-6.82%
Revenue growth 3Y0.43%
Revenue growth 5YN/A
Sales Q2Q%-6.64%

3.2 Future

The Earnings Per Share is expected to grow by 4.00% on average over the next years.
Based on estimates for the next years, BELYS will show a small growth in Revenue. The Revenue will grow by 0.59% on average per year.
EPS Next Y-58.33%
EPS Next 2Y-20.94%
EPS Next 3Y4%
EPS Next 5YN/A
Revenue Next Year-1.43%
Revenue Next 2Y0.18%
Revenue Next 3Y0.59%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BELYS.BR Yearly Revenue VS EstimatesBELYS.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
BELYS.BR Yearly EPS VS EstimatesBELYS.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 2.48, which indicates a rather cheap valuation of BELYS.
96.97% of the companies in the same industry are more expensive than BELYS, based on the Price/Earnings ratio.
BELYS is valuated cheaply when we compare the Price/Earnings ratio to 26.25, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 6.99 indicates a rather cheap valuation of BELYS.
Based on the Price/Forward Earnings ratio, BELYS is valued cheaper than 81.82% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BELYS to the average of the S&P500 Index (22.15), we can say BELYS is valued rather cheaply.
Industry RankSector Rank
PE 2.48
Fwd PE 6.99
BELYS.BR Price Earnings VS Forward Price EarningsBELYS.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BELYS indicates a rather cheap valuation: BELYS is cheaper than 84.85% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, BELYS is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 0.86
EV/EBITDA 3.62
BELYS.BR Per share dataBELYS.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-20.94%
EPS Next 3Y4%

0

5. Dividend

5.1 Amount

BELYS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BELYSSE GROUP NV

EBR:BELYS (5/30/2025, 7:00:00 PM)

0.72

-0.02 (-2.7%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)04-25 2025-04-25
Earnings (Next)09-05 2025-09-05
Inst Owners13.1%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap25.88M
Analysts84.44
Price Target1.63 (126.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)11.11%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.16%
Revenue NY rev (3m)-2.82%
Valuation
Industry RankSector Rank
PE 2.48
Fwd PE 6.99
P/S 0.09
P/FCF 0.86
P/OCF 0.64
P/B 0.27
P/tB N/A
EV/EBITDA 3.62
EPS(TTM)0.29
EY40.28%
EPS(NY)0.1
Fwd EY14.31%
FCF(TTM)0.83
FCFY115.67%
OCF(TTM)1.12
OCFY155.09%
SpS7.8
BVpS2.66
TBVpS-0.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.3%
ROE 11.07%
ROCE 8.77%
ROIC 7.18%
ROICexc 8.43%
ROICexgc 17.07%
OM 8.15%
PM (TTM) 3.77%
GM 60.82%
FCFM 10.68%
ROA(3y)-6.3%
ROA(5y)-7.85%
ROE(3y)-25.25%
ROE(5y)-43.19%
ROIC(3y)7.13%
ROIC(5y)5.99%
ROICexc(3y)9.09%
ROICexc(5y)7.47%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.69%
ROCE(5y)7.3%
ROICexcg growth 3Y21.04%
ROICexcg growth 5YN/A
ROICexc growth 3Y8.96%
ROICexc growth 5YN/A
OM growth 3Y-5.23%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.7%
GM growth 5YN/A
F-Score6
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 1.64
Debt/FCF 5.56
Debt/EBITDA 3.69
Cap/Depr 52.09%
Cap/Sales 3.64%
Interest Coverage 1.06
Cash Conversion 94.56%
Profit Quality 283.09%
Current Ratio 1.78
Quick Ratio 0.95
Altman-Z 0.34
F-Score6
WACC10.8%
ROIC/WACC0.67
Cap/Depr(3y)58.36%
Cap/Depr(5y)60.35%
Cap/Sales(3y)3.69%
Cap/Sales(5y)3.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)193.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.25%
EPS Next Y-58.33%
EPS Next 2Y-20.94%
EPS Next 3Y4%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.82%
Revenue growth 3Y0.43%
Revenue growth 5YN/A
Sales Q2Q%-6.64%
Revenue Next Year-1.43%
Revenue Next 2Y0.18%
Revenue Next 3Y0.59%
Revenue Next 5YN/A
EBIT growth 1Y65.79%
EBIT growth 3Y-4.83%
EBIT growth 5YN/A
EBIT Next Year86.36%
EBIT Next 3Y25.99%
EBIT Next 5YN/A
FCF growth 1Y55.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y29.24%
OCF growth 3YN/A
OCF growth 5YN/A